Session 2: Expanding Frontiers of Genomic Medicine Enabled by Cost-Effective Next Generation Sequencing

Whole genome bisulfite sequencing (WGBS) enables a comprehensive analysis of an individual's DNA methylation profile and has the potential to enhance precision medicine initiatives by addressing both genetic and epigenetic factors simultaneously. Collecting DNA methylation data by WGBS offers valuable insights into disease origin, predisposition, and treatment response, potentially guiding therapeutic strategies. | Whole genome bisulfite sequencing (WGBS) enables a comprehensive analysis of an individual's DNA methylation profile and has the potential to enhance precision medicine initiatives by addressing both genetic and epigenetic factors simultaneously.

Best practices for the analytical validation of clinical whole-genome sequencing intended for the diagnosis of germline disease

Forward-Looking Advances for Human Genetics and Genomics - ASHG

Increasing access to next-generation sequencing in oncology for Brazil - The Lancet Oncology

Multiomics - Wikipedia

Frontiers Microbiome in Death and Beyond: Current Vistas and Future Trends

Content pack: Sanger Sequencing and Fragment Analysis applications

General Meeting - AGBT

Frontiers Hybrid Capture-Based Next Generation Sequencing and Its Application to Human Infectious Diseases

Company Events — Biological Dynamics - Next-Generation Liquid Biopsy

ISPOR - Accelerating Patient Access to Next-Generation Sequencing in Oncology: A Plan of Action

eSymposia On Demand - Keystone Symposia

NGS: hunting 'Dark Matter Genome' - rewriting rules of human genetic diseases

Frontiers Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings: a programmatic model, challenges, and initial outcomes